News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Natera’s Non-Invasive Prenatal Testing Technology Shows Unparalleled Specificity, Sensitivity in Clinical Data Presented at American Society of Human Genetics



11/9/2012 11:07:03 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera presented additional data from an ongoing clinical study of the company’s non-invasive prenatal screening test that demonstrates consistently high detection of chromosomal abnormalities from fetal cell-free DNA found in maternal blood. The data were presented in a poster presentation at the annual meeting of the American Society of Human Genetics in San Francisco on Thursday, November 8.

Read at BioSpace.com

Related News

comments powered by Disqus
   
Pregnancy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES